By Social media has been buzzing with news of the revolutionary new breast cancer drug, Enhertu®, and how it will be able to extend and enhance the lives of late-stage and metastatic breast cancer survivors. Make no mistake, this is great news but, in a South African context, how beneficial is Enhertu® really?
Paying the Price Because of Gauteng’s Radiation Oncology Crisis
Paying the Price Because of Gauteng’s Radiation Oncology Crisis Public sector cancer patients bear the brunt of Gauteng’s Radiation Oncology Crisis. The implications of long radiation oncology waiting lists in Gauteng’s public hospitals are devastating. The cost of waiting too long for radiation therapy comes at a price far exceeding
An Open Letter to Dr. Nolutshungu, New Head of the Gauteng Department of Health, Concerning the Radiation Oncology Crisis
An Open Letter to Dr. Nolutshungu, New Head of the Gauteng Department of Health, Concerning the Radiation Oncology Crisis Dear Nomonde, Congratulations & Enjoy the Challenge Firstly, congratulations on your recent appointment. I trust that you will be able to make some inroads into the huge challenges that presently face
Due to the Oncology Crisis in Gauteng Public Hospitals, Is There Any Hope Left for Inflammatory Breast Cancer Patients in South Africa?
Due to the Oncology Crisis in Gauteng Public Hospitals, Is There Any Hope Left for Inflammatory Breast Cancer Patients in South Africa? Inflammatory Breast Cancer (IBC) is certainly breast cancer. In fact, it’s a breast cancer overachiever. It is extremely rare, incredibly volatile and has a competitive spirit that makes
